0001578563-24-000186.txt : 20240409 0001578563-24-000186.hdr.sgml : 20240409 20240409165814 ACCESSION NUMBER: 0001578563-24-000186 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 EFFECTIVENESS DATE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510110 FILM NUMBER: 24833374 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 D 1 primary_doc.xml X0708 D LIVE 0001534120 Avalo Therapeutics, Inc. 540 GAITHER ROAD SUITE 400 ROCKVILLE MD MARYLAND 20850 410-522-8707 DELAWARE Cerecor Inc. Corporation true Garry Neil, M.D. c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Executive Officer Director June Almenoff, M.D., Ph.D. c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Mitchell Chan c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Jonathan Goldman, M.D. c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Aaron Kantoff c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Gilla Kaplan, Ph.D. c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Magnus Persson, M.D., Ph.D. c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Samantha Truex c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Director Christopher Sullivan c/o Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD MARYLAND 20850 Executive Officer Biotechnology Decline to Disclose 06b false 2024-03-27 false true true true The offering is made in connection with the merger of Project Athens Merger Sub, Inc. into AlmataBio, Inc. and AlmataBio, Inc. into Second Project Athens Merger Sub, LLC, pursuant to an Agreement and Plan of Merger and Reorganization dated March 27, 2024. 0 Oppenheimer & Co. Inc. 249 None None 85 Broad Street 4th Floor New York NY NEW YORK 10004 All States false 199976986 130601986 69375000 The Total Remaining to be Sold represents warrants issued at closing that have not yet been exercised. false 25 0 6937500 0 Other than the payment of salaries and other compensation and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Avalo Therapeutics, Inc. /s/ Garry A. Neil Garry A. Neil Chief Executive Officer 2024-04-09